USPTO serial 86633739
MERIT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 28, 2017
- Examiner
- KHAN, ASMAT A
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MERIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Merit Healthcare International, Inc.
Los Angeles, CA, US
Other trademarks owned by Merit Healthcare International, Inc.
Merit Healthcare International, Inc.
Los Angeles, CA, US
Other trademarks owned by Merit Healthcare International, Inc.
Merit Healthcare International, Inc.
Los Angeles, CA, US
Other trademarks owned by Merit Healthcare International, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew J. Clark
Matthew J. Clark FBT Gibbons LLP111 Monument CircleSuite 4500INDIANAPOLIS, IN 46204Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Sterile non-pyrogenic distilled water used as a diluent for parenteral injection solutions ] | SECTION 8 - CANCELLED | Jun 25, 1982 |
| 005 | [ Pharmaceuticals for the treatment of medical conditions, namely, prescription pharmaceutical products, oral pharmaceuticals, and topical pharmaceuticals for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Vaccines; ] Nutritional supplements; [ Pharmaceutical preparations, namely, general anesthetics, sedatives, anti-infectives, cardiovascular pharmaceuticals, anti-emetics, and diluents for use in reconstituting and diluting other pharmaceutical agents; ] Dietetic substances, namely, vitamins [, lipids, amino acids for medical purposes, and electrolytes; Full line of pharmaceutical preparations for intravenous administration, namely, electrolytes, saline solution for medical purposes, dextrose, heparin, lactated ringers; Anti-infective agents; Medical solutions for intermittent or continuous intravenous infusion for treatment of cardiovascular disease, prevention or treatment of infections; Critical care premixed medicines for fluid replacement; Medicated skin ointment; Medical solutions for wound irrigation; Fluids for parenteral medical use, namely, mineral, vitamin, or nutritionally enhanced water for injection for medical purposes, dextrose in water, dextrose and sodium chloride in water, sodium chloride in water, dextrose and vitamins in water, dextrose, sodium chloride, and vitamins in water, dextrose, alcohol, sodium chloride, and vitamins in water, dextrose, alcohol, and vitamins in water, sodium chloride, potassium chloride, and calcium chloride in water, dextrose, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate in water, sodium r-lactate, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate, sodium chloride, potassium chloride, calcium chloride, and dextrose in water, dextrose, alcohol, and sodium chloride in water, hydrolyzed protein in water, and sodium sulfate in water, for medical purposes; Solutions for parenteral medical use, namely, various concentrations of dextrose in water, various concentrations of dextrose and sodium chloride in water, various concentrations of sodium chloride in water, various concentrations of vitamins in water, various concentrations of dextrose with sodium chloride and vitamins in water, various concentrations of dextrose and alcohol with sodium chloride and vitamins in water, various concentrations of dextrose and alcohol with vitamins in water, sodium chloride, potassium chloride, and calcium chloride in water, various concentrations of calcium chloride in water, sodium r-lactate, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate in water, various concentrations of dextrose and alcohol with sodium chloride in water, various concentrations of dextrose and alcohol in water, various concentrations of magnesium sulfate in water, for medical purposes; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Various concentrations of sodium citrate in water, various concentrations of potassium chloride, sodium chloride, and sodium lactate in water, various concentrations of potassium chloride in water, various concentrations of invert sugar in water, various concentrations of invert sugar and sodium chloride in water, and sodium chloride, potassium chloride, and calcium chloride with dextrose in water for medical purposes; Solutions for enteral use, namely, various concentrations of hydrolyzed protein with carbohydrates and minerals in water for medical purposes; Blood anticoagulant and preservative agents, namely, heparin; Various concentrations of sodium citrate in water for medical purposes, various concentrations of dextrose, sodium citrate, and sodium chloride in water for medical purposes, and various concentrations of citric acid in water for medical purposes ] | ACTIVE | — |
| 044 | [ Providing information relating to therapeutic properties of pharmaceuticals relating to the treatment of medical conditions to healthcare providers and patients ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merit Healthcare International, Inc.
- Other trademarks owned by Merit Healthcare International, Inc.
- Other trademarks owned by Merit Healthcare International, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named MERIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Feb 28, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Feb 13, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 13, 2024 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 13, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 28, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 28, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 2, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 2, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 27, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 28, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 13, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 31, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 25, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 28, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 27, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |